首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   18371篇
  免费   1523篇
  国内免费   38篇
耳鼻咽喉   168篇
儿科学   606篇
妇产科学   377篇
基础医学   2273篇
口腔科学   470篇
临床医学   2254篇
内科学   3447篇
皮肤病学   339篇
神经病学   1812篇
特种医学   628篇
外科学   2339篇
综合类   395篇
一般理论   21篇
预防医学   2003篇
眼科学   423篇
药学   1279篇
中国医学   20篇
肿瘤学   1078篇
  2022年   138篇
  2021年   309篇
  2020年   222篇
  2019年   335篇
  2018年   431篇
  2017年   319篇
  2016年   358篇
  2015年   391篇
  2014年   537篇
  2013年   749篇
  2012年   1152篇
  2011年   1207篇
  2010年   657篇
  2009年   533篇
  2008年   1033篇
  2007年   1107篇
  2006年   1066篇
  2005年   991篇
  2004年   1006篇
  2003年   826篇
  2002年   852篇
  2001年   384篇
  2000年   366篇
  1999年   344篇
  1998年   211篇
  1997年   176篇
  1996年   166篇
  1995年   115篇
  1994年   145篇
  1993年   160篇
  1992年   299篇
  1991年   254篇
  1990年   216篇
  1989年   203篇
  1988年   198篇
  1987年   189篇
  1986年   183篇
  1985年   165篇
  1984年   136篇
  1983年   117篇
  1982年   106篇
  1981年   103篇
  1980年   103篇
  1979年   93篇
  1978年   92篇
  1977年   86篇
  1976年   94篇
  1974年   80篇
  1973年   98篇
  1972年   87篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
PurposeOur purpose was to determine the effect of chemoradiotherapy (CRT) on patient-reported quality of life (QOL) for patients with intact pancreas cancer.Methods and MaterialsWe reviewed a prospective QOL registry for patients with intact, clinically localized pancreatic ductal adenocarcinoma treated with CRT between June 2015 and November 2018. QOL was assessed pre-CRT (immediately before CRT, after neoadjuvant chemotherapy) and at the completion of CRT with the Functional Assessment of Cancer Therapy-Hepatobiliary (FACT-Hep) and its component parts: FACT-General (FACT-G) and hepatobiliary cancer subscore (HCS). A minimally important difference from pre-CRT was defined as ≥ 6, 5, and 8 points for FACT-G, HCS, and FACT-Hep, respectively.ResultsOf 157 patients who underwent CRT, 100 completed both pre- and post-CRT surveys and were included in the primary analysis. Median age at diagnosis was 65 years (range, 23-90). National Comprehensive Cancer Network resectability status was resectable (3%), borderline resectable (40%), or locally advanced (57%). Folinic acid, 5-fluorouracil, irinotecan, and oxaliplatin (FOLFIRINOX) (75%) or gemcitabine and nab-paclitaxel (42%) were given for a median of 6 cycles (range, 0-42) before CRT. Radiation therapy techniques included 3-dimensional conformal (22%), intensity modulated photon (55%), and intensity modulated proton (23%) radiation therapy to a median dose of 50 Gy (range, 36-62.5). Concurrent chemotherapy was most commonly capecitabine (82%). Sixty-three patients (63%) had surgery after CRT. The mean decline in FACT-G, HCS subscale, and FACT-Hep from pre- to post-CRT was 3.5 (standard deviation [SD], 13.7), 1.7 (SD 7.8), and 5.2 (SD 19.4), respectively. Each of these changes were statistically significant, but did not meet the minimally important difference threshold. Pancreatic head tumor location was associated with decline in FACT-Hep. Nausea was the toxicity with the greatest increase from pre- to post-CRT by both physician-assessment and patient-reported QOL.ConclusionsFor patients with intact pancreatic adenocarcinoma, modern CRT is well tolerated with minimal decline in QOL during treatment.  相似文献   
5.
6.
Marie Warrer Petersen  Tine Sylvest Meyhoff  Marie Helleberg  Maj-Brit Nørregaard Kjær  Anders Granholm  Carl Johan Steensen Hjortsø  Thomas Steen Jensen  Morten Hylander Møller  Peter Buhl Hjortrup  Mik Wetterslev  Gitte Kingo Vesterlund  Lene Russell  Vibeke Lind Jørgensen  Klaus Tjelle  Thomas Benfield  Charlotte Suppli Ulrik  Anne Sofie Andreasen  Thomas Mohr  Morten H. Bestle  Lone Musaeus Poulsen  Mette Friberg Hitz  Thomas Hildebrandt  Lene Surland Knudsen  Anders Møller  Christoffer Grant Sølling  Anne Craveiro Brøchner  Bodil Steen Rasmussen  Henrik Nielsen  Steffen Christensen  Thomas Strøm  Maria Cronhjort  Rebecka Rubenson Wahlin  Stephan Jakob  Luca Cioccari  Balasubramanian Venkatesh  Naomi Hammond  Vivekanand Jha  Sheila Nainan Myatra  Christian Gluud  Theis Lange  Anders Perner 《Acta anaesthesiologica Scandinavica》2020,64(9):1365-1375

Introduction

Severe acute respiratory syndrome coronavirus-2 has caused a pandemic of coronavirus disease (COVID-19) with many patients developing hypoxic respiratory failure. Corticosteroids reduce the time on mechanical ventilation, length of stay in the intensive care unit and potentially also mortality in similar patient populations. However, corticosteroids have undesirable effects, including longer time to viral clearance. Clinical equipoise on the use of corticosteroids for COVID-19 exists.

Methods

The COVID STEROID trial is an international, randomised, stratified, blinded clinical trial. We will allocate 1000 adult patients with COVID-19 receiving ≥10 L/min of oxygen or on mechanical ventilation to intravenous hydrocortisone 200 mg daily vs placebo (0.9% saline) for 7 days. The primary outcome is days alive without life support (ie mechanical ventilation, circulatory support, and renal replacement therapy) at day 28. Secondary outcomes are serious adverse reactions at day 14; days alive without life support at day 90; days alive and out of hospital at day 90; all-cause mortality at day 28, day 90, and 1 year; and health-related quality of life at 1 year. We will conduct the statistical analyses according to this protocol, including interim analyses for every 250 patients followed for 28 days. The primary outcome will be compared using the Kryger Jensen and Lange test in the intention to treat population and reported as differences in means and medians with 95% confidence intervals.

Discussion

The COVID STEROID trial will provide important evidence to guide the use of corticosteroids in COVID-19 and severe hypoxia.
  相似文献   
7.
BACKGROUND: Stringent transcranial Doppler (TCD) criteria for diagnosing occlusion are needed for more reliable TCD performance at bedside in the acute stroke setting. SUBJECTS AND METHODS: At three academic stroke centers, we performed TCD examination for patients with symptoms of cerebral ischemia who underwent digital subtraction angiography (DSA). We used a standard insonation protocol with power M-mode Doppler (PMD) TCD (TCD 100 M, Spencer Technologies Inc., Seattle, WA). We collected mean flow velocity (MFV), pulsatility indices (PI), and power M-mode resistance signature (absent, high, or low) in symptomatic middle (MCA), anterior (ACA), posterior (PCA), and in affected (a), ipsilateral (i), and contralateral (c-lat) cerebral arteries. Ratios of aMCA/c-lat MCA, aMCA/iACA, and aMCA/iPCA MFV were subsequently calculated. PMD-TCD flow findings were evaluated with a receiver-operating characteristic (ROC) analysis for angiographically proven MCA occlusion. RESULTS: We studied 120 patients with acute cerebral ischemia with PMD-TCD examinations prior to or immediately after DSA. Lower aMCA velocities pointed to higher probability of occlusion (P= .055). The aMCA/iPCA MFV ratio was superior to the aMCA/iACA ratio and strongly predictive of occlusion at a threshold ratio of 0.5 (RR 2.31 CI(95) 2.13-2.51). High resistance or absent M-mode flow signatures in the proximal MCA were present in 87% of M1 and M2 MCA occlusions (probability 87%). In the presence of a low-resistance PMD signature, obtaining the aMCA/iPCA MFV ratio <0.5 increases probability of occlusion to 87%. Normal MFV ratios and low-resistance M-mode signatures are highly predictive of a negative angiogram for MCA occlusion. CONCLUSION: In acute cerebral ischemia, reliable criteria for proximal MCA occlusion have been developed based on combination of MFV ratios and M-mode flow resistance signatures. Validation of these criteria will require multicenter studies.  相似文献   
8.
9.
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号